Adviser Investments LLC Abb Vie Inc. Transaction History

Adviser Investments LLC

$7.95 Billion
Q3 2024

A detailed history of Adviser Investments LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Adviser Investments LLC holds 306,367 shares of ABBV stock, worth $53 Million. This represents 0.76% of its overall portfolio holdings.

Number of Shares

306,367

Previous 319,532 4.12%

Holding current value

$53 Million

Previous $54.8 Million 10.39%

% of portfolio

0.76%

Previous 0.73%

30 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 08, 2024	SELL	$163.84 - $199.33 $2.16 Million - $2.62 Million	-13,165 Reduced 4.12%	306,367 $60.5 Million
Q2 2024 Aug 12, 2024	BUY	$154.79 - $180.76 $1.94 Million - $2.26 Million	12,521 Added 4.08%	319,532 $54.8 Million
Q1 2024 Apr 29, 2024	SELL	$159.82 - $182.1 $2.06 Million - $2.35 Million	-12,903 Reduced 4.03%	307,011 $55.9 Million
Q4 2023 Feb 01, 2024	BUY	$137.6 - $154.97 $32.4 Million - $36.4 Million	235,137 Added 277.36%	319,914 $49.6 Million
Q3 2023 Oct 11, 2023	BUY	$133.59 - $154.65 $364,700 - $422,194	2,730 Added 3.33%	84,777 $12.6 Million
Q2 2023 Aug 04, 2023	BUY	$132.51 - $164.9 $1.3 Million - $1.62 Million	9,818 Added 13.59%	82,047 $11.1 Million
Q1 2023 Apr 25, 2023	BUY	$144.61 - $166.54 $223,277 - $257,137	1,544 Added 2.18%	72,229 $11.5 Million
Q4 2022 Jan 19, 2023	BUY	$138.31 - $165.87 $341,072 - $409,035	2,466 Added 3.61%	70,685 $0
Q3 2022 Oct 14, 2022	BUY	$134.21 - $153.93 $240,504 - $275,842	1,792 Added 2.7%	68,219 $9.16 Million
Q2 2022 Jul 14, 2022	BUY	$137.62 - $174.96 $236,018 - $300,056	1,715 Added 2.65%	66,427 $10.2 Million
Q1 2022 May 04, 2022	BUY	$131.98 - $163.75 $307,909 - $382,028	2,333 Added 3.74%	64,712 $10.5 Million
Q4 2021 Jan 31, 2022	BUY	$107.43 - $135.93 $138,154 - $174,805	1,286 Added 2.1%	62,379 $8.45 Million
Q3 2021 Nov 05, 2021	BUY	$106.4 - $120.78 $65,010 - $73,796	611 Added 1.01%	61,093 $6.59 Million
Q2 2021 Jul 09, 2021	SELL	$105.21 - $117.21 $2.02 Million - $2.25 Million	-19,172 Reduced 24.07%	60,482 $6.81 Million
Q1 2021 May 05, 2021	BUY	$102.3 - $112.62 $1.05 Million - $1.16 Million	10,258 Added 14.78%	79,654 $8.62 Million
Q4 2020 Jan 26, 2021	SELL	$80.49 - $108.67 $258,453 - $348,939	-3,211 Reduced 4.42%	69,396 $7.44 Million
Q3 2020 Nov 13, 2020	BUY	$85.91 - $100.83 $441,835 - $518,568	5,143 Added 7.62%	72,607 $6.36 Million
Q2 2020 Aug 03, 2020	BUY	$73.37 - $98.18 $29,421 - $39,370	401 Added 0.6%	67,464 $6.62 Million
Q1 2020 Apr 08, 2020	BUY	$64.5 - $97.79 $18,511 - $28,065	287 Added 0.43%	67,063 $5.11 Million
Q4 2019 Feb 07, 2020	SELL	$72.13 - $90.25 $28,924 - $36,190	-401 Reduced 0.6%	66,776 $5.91 Million
Q3 2019 Nov 13, 2019	BUY	$62.98 - $75.72 $99,634 - $119,789	1,582 Added 2.41%	67,177 $5.09 Million
Q2 2019 Aug 12, 2019	SELL	$65.7 - $83.98 $181,397 - $231,868	-2,761 Reduced 4.04%	65,595 $4.77 Million
Q1 2019 May 07, 2019	SELL	$77.14 - $90.79 $21,830 - $25,693	-283 Reduced 0.41%	68,356 $5.51 Million
Q4 2018 Jan 25, 2019	BUY	$77.85 - $96.01 $405,676 - $500,308	5,211 Added 8.22%	68,639 $6.33 Million
Q3 2018 Nov 14, 2018	BUY	$88.91 - $98.84 $107,403 - $119,398	1,208 Added 1.94%	63,428 $6 Million
Q2 2018 Aug 02, 2018	BUY	$89.78 - $106.23 $82,148 - $97,200	915 Added 1.49%	62,220 $5.77 Million
Q1 2018 May 14, 2018	SELL	$92.01 - $123.21 $4.52 Million - $6.06 Million	-49,168 Reduced 44.51%	61,305 $5.8 Million
Q4 2017 Feb 12, 2018	SELL	$89.56 - $98.21 $122,159 - $133,958	-1,364 Reduced 1.22%	110,473 $10.7 Million
Q3 2017 Oct 23, 2017	SELL	$69.85 - $89.22 $1.05 Million - $1.34 Million	-15,058 Reduced 11.87%	111,837 $9.94 Million
Q2 2017 Aug 14, 2017	BUY	N/A	126,895	126,895 $9.2 Million

Others Institutions Holding ABBV

# of Institutions

3,853

Shares Held

1.25B

Call Options Held

16.8M

Put Options Held

12.2M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $306B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Adviser Investments LLC, based on Form 13F filings with the SEC.

News

Stay updated on Adviser Investments LLC with notifications on news.

Account

Adviser Investments LLC Abb Vie Inc. Transaction History